E-LIB Suche - Ergebnisse für: Keshishian, A.

1

EE411 Healthcare Costs of Direct Oral Anticoagulants Among ..:

Dhamane, AD ; Ferri, M ; Keshishian, A...
Value in Health. 25 (2022) 7 - p. S415 , 2022

Link: https://doi.org/10.1016/..

2

Time at home among nonvalvular atrial fibrillation patients..:

Deitelzweig, S ; Keshishian, A ; Kang, A...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

3

Effectiveness and safety of apixaban vs warfarin among veno..:

Cohen, A ; Sah, J ; Dhamane, A...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

4

Effectiveness and safety of apixaban vs warfarin among olde..:

Cohen, A ; Sah, J ; Dhamane, A...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

5

Effectiveness and safety of non-vitamin K antagonist oral a..:

Lip, G.Y.H ; Keshishian, A ; Kang, A...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

6

Time at home among nonvalvular atrial fibrillation patients..:

Deitelzweig, S ; Keshishian, A ; Kang, A...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

7

Effectiveness and safety of apixaban vs warfarin among olde..:

Cohen, A ; Sah, J ; Dhamane, A...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

8

Effectiveness and safety of non-vitamin K antagonist oral a..:

Lip, G.Y.H ; Keshishian, A ; Kang, A...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

9

Effectiveness and safety of apixaban, low-molecular weight ..:

Cohen, A ; Keshishian, A ; Lee, T...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

10

PIN42 COMPARISON OF ECONOMIC BURDEN AND RISK OF HOSPITALIZA..:

Delinger, R. ; Ratiu, A. ; Xie, L..
Value in Health. 23 (2020) - p. S175 , 2020

Link: https://doi.org/10.1016/..

11

PDB18 ASSESSMENT OF THE HEALTH CARE UTILIZATION AND ECONOMI..:

Delinger, R. ; Ratiu, A. ; Xie, L..
Value in Health. 23 (2020) - p. S111 , 2020

Link: https://doi.org/10.1016/..

12

P5589Patterns of extended apixaban treatment for unprovoked..:

Keshishian, A ; Lee, T ; Wygant, G...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

13

PRS40 EXAMINING THE RISK FACTORS OF CHRONIC OBSTRUCTIVE PUL..:

Wang, H. ; Qiang, W. ; Delinger, R....
Value in Health. 22 (2019) - p. S356 , 2019

Link: https://doi.org/10.1016/..

14

P4768Comparative effectiveness and safety between non-VKA o..:

Deitelzweig, S ; Keshishian, A ; Kang, A...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

15

Comparative effectiveness and safety of non-vitamin K antag..:

Galinier, M. ; Deitelzweig, S. ; Keshishian, A....
Archives of Cardiovascular Diseases Supplements. 11 (2019) 1 - p. 150 , 2019

Link: https://doi.org/10.1016/..